Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene-modified, personalized cell therapy UCSF
IND
Neurological Disorders Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
IND
B cell cancers,
Solid Tumors
Cancer Stem Cell Biologic Nammi Therapeutics, Inc.
IND
B cell cancers Somatic Cell Gene-modified, donor cell therapy Angiocrine
Clinical Trial, Phase 3
Immune Disease Adult Stem Cell Donor cell therapy Ossium Health
IND
Parkinson's Disease iPS Cell Donor cell therapy Ryne Bio
IND
Bone or Cartilage Disease,
Hearing Loss,
Intellectual Disability,
Metabolic Disorders,
Vision Loss
Somatic Cell Personalized cell therapy Immusoft Corporation
Clinical Trial, Phase 1 or Phase 1/2
Spinal Cord Injury Embryonic Stem Cell,
iPS Cell
Gene-modified, personalized cell therapy BrainXell Therapeutics
Development Candidate, Proof of Concept
Heart failure iPS Cell Gene Therapy, cell free UC Berkeley
Development Candidate, Proof of Concept
Neurological Disorders,
Sanfilippo Syndrome/MPS III
Embryonic Stem Cell Gene-modified, donor cell therapy Lundquist Institute
Development Candidate, Proof of Concept
Intervertebral disc degeneration iPS Cell Donor cell therapy Cedars-Sinai
Proof of Concept
Tendon/Ligament/Connective Tissue Injury or Disorder Embryonic Stem Cell Biologic Scripps Health
Development Candidate, Proof of Concept
Brain Cancer Cancer Stem Cell Small molecule therapy UCLA
Development Candidate
Autism,
Intellectual Disability,
Metabolic Disorders
iPS Cell Gene Therapy, cell free UCLA
Development Candidate, Proof of Concept
Lung Disease, Fibrosis Adult Stem Cell Small molecule therapy Rubedo Life Sciences Inc.
Development Candidate, Proof of Concept
Duchenne Muscular Dystrophy Other,
Somatic Cell
Gene Therapy, cell free UC Davis
Proof of Concept
UC Berkeley
Greenstone Biosciences
Breast Cancer Adult Stem Cell Small molecule therapy UCLA
Development Candidate, Proof of Concept
UCLA
Spinal Cord Injury Embryonic Stem Cell,
iPS Cell
Donor cell therapy Gladstone
Development Candidate, Proof of Concept
COH
Metabolic Disorders Adult Stem Cell Gene-modified, personalized cell therapy Rampart Bioscience
IND
Osteoarthritis Somatic Cell Gene Therapy, cell free Genascence Corporation
Clinical Trial, Phase 1 or Phase 1/2

Pages

Icon for csv export